Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 3061129
[patent_doc_number] => 05352449
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-04
[patent_title] => 'Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant'
[patent_app_type] => 1
[patent_app_number] => 7/869082
[patent_app_country] => US
[patent_app_date] => 1992-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 32
[patent_no_of_words] => 8410
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/352/05352449.pdf
[firstpage_image] =>[orig_patent_app_number] => 869082
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/869082 | Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant | Apr 13, 1992 | Issued |
Array
(
[id] => 3492373
[patent_doc_number] => 05470997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-11-28
[patent_title] => 'Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels'
[patent_app_type] => 1
[patent_app_number] => 7/864108
[patent_app_country] => US
[patent_app_date] => 1992-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5873
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/470/05470997.pdf
[firstpage_image] =>[orig_patent_app_number] => 864108
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/864108 | Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels | Apr 5, 1992 | Issued |
07/864107 | NOVEL OPIATE DERIVATIVES AND PROTEIN AND POLYPEPTIDE OPIATE DERIVATIVE CONJUGATES AND LABELS | Apr 5, 1992 | Abandoned |
Array
(
[id] => 3010098
[patent_doc_number] => 05331109
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-07-19
[patent_title] => 'Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels'
[patent_app_type] => 1
[patent_app_number] => 7/864104
[patent_app_country] => US
[patent_app_date] => 1992-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3765
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/331/05331109.pdf
[firstpage_image] =>[orig_patent_app_number] => 864104
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/864104 | Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels | Apr 5, 1992 | Issued |
Array
(
[id] => 3446774
[patent_doc_number] => 05387578
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-02-07
[patent_title] => 'New linker for bioactive agents'
[patent_app_type] => 1
[patent_app_number] => 7/842171
[patent_app_country] => US
[patent_app_date] => 1992-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8714
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/387/05387578.pdf
[firstpage_image] =>[orig_patent_app_number] => 842171
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/842171 | New linker for bioactive agents | Apr 2, 1992 | Issued |
07/858798 | PRIMATE INTRA-ACROSOMAL SPERM ANTIGEN FOR USE IN A CONTRACEPTIVE VACCINE | Mar 26, 1992 | Abandoned |
07/857058 | METHODS FOR MODIFYING THE BINDING ACTIVITY OF CELL ADHESION RECEPTORS | Mar 22, 1992 | Abandoned |
Array
(
[id] => 2971792
[patent_doc_number] => 05182107
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-01-26
[patent_title] => 'Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates'
[patent_app_type] => 1
[patent_app_number] => 7/846830
[patent_app_country] => US
[patent_app_date] => 1992-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 12017
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/182/05182107.pdf
[firstpage_image] =>[orig_patent_app_number] => 846830
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/846830 | Transferrin receptor specific antibody-neuropharmaceutical or diagnostic agent conjugates | Mar 5, 1992 | Issued |
07/839729 | IMMUNOCONJUGATES FOR CANCER DIAGNOSIS AND THERAPY | Feb 18, 1992 | Abandoned |
07/832625 | MAGNETIC PROTEIN CONJUGATES, A PROCESS FOR THE PREPARATION THEREOF, AND THE USE THEREOF | Feb 11, 1992 | Abandoned |
Array
(
[id] => 3456504
[patent_doc_number] => 05378815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-03
[patent_title] => 'Process for indirect targeted immunocytolysis'
[patent_app_type] => 1
[patent_app_number] => 7/872966
[patent_app_country] => US
[patent_app_date] => 1992-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 5235
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/378/05378815.pdf
[firstpage_image] =>[orig_patent_app_number] => 872966
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/872966 | Process for indirect targeted immunocytolysis | Feb 9, 1992 | Issued |
07/832994 | DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN (A) | Feb 9, 1992 | Abandoned |
Array
(
[id] => 2898338
[patent_doc_number] => 05217881
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-06-08
[patent_title] => 'Hyperglycosylated cytokine conjugates'
[patent_app_type] => 1
[patent_app_number] => 7/827517
[patent_app_country] => US
[patent_app_date] => 1992-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6493
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/217/05217881.pdf
[firstpage_image] =>[orig_patent_app_number] => 827517
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/827517 | Hyperglycosylated cytokine conjugates | Jan 23, 1992 | Issued |
Array
(
[id] => 3003613
[patent_doc_number] => 05354554
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-11
[patent_title] => 'Crosslinked antibodies and processes for their preparation'
[patent_app_type] => 1
[patent_app_number] => 7/824867
[patent_app_country] => US
[patent_app_date] => 1992-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6100
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/354/05354554.pdf
[firstpage_image] =>[orig_patent_app_number] => 824867
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/824867 | Crosslinked antibodies and processes for their preparation | Jan 21, 1992 | Issued |
07/821031 | M-PROTEIN PEPTIDES OF INFLUENZA VIRUS AS ANTIVIRAL AGENTS | Jan 15, 1992 | Abandoned |
Array
(
[id] => 2976867
[patent_doc_number] => 05208323
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-05-04
[patent_title] => 'Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent'
[patent_app_type] => 1
[patent_app_number] => 7/819669
[patent_app_country] => US
[patent_app_date] => 1992-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2942
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/208/05208323.pdf
[firstpage_image] =>[orig_patent_app_number] => 819669
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/819669 | Coupling of an anti-tumor to an antibody using glutaraldehyde preactivated anti-tumor agent | Jan 12, 1992 | Issued |
Array
(
[id] => 3073825
[patent_doc_number] => 05360897
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-01
[patent_title] => 'Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad'
[patent_app_type] => 1
[patent_app_number] => 7/819305
[patent_app_country] => US
[patent_app_date] => 1992-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10978
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/360/05360897.pdf
[firstpage_image] =>[orig_patent_app_number] => 819305
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/819305 | Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad | Jan 8, 1992 | Issued |
Array
(
[id] => 3458354
[patent_doc_number] => 05441867
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-08-15
[patent_title] => 'Pre-activated proteins for labelling oligonucleotide probes'
[patent_app_type] => 1
[patent_app_number] => 7/815881
[patent_app_country] => US
[patent_app_date] => 1992-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4967
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/441/05441867.pdf
[firstpage_image] =>[orig_patent_app_number] => 815881
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/815881 | Pre-activated proteins for labelling oligonucleotide probes | Jan 6, 1992 | Issued |
07/807942 | PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE | Dec 18, 1991 | Abandoned |
Array
(
[id] => 2957112
[patent_doc_number] => 05273743
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-12-28
[patent_title] => 'Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent'
[patent_app_type] => 1
[patent_app_number] => 7/808193
[patent_app_country] => US
[patent_app_date] => 1991-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16180
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/273/05273743.pdf
[firstpage_image] =>[orig_patent_app_number] => 808193
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/808193 | Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent | Dec 12, 1991 | Issued |